NeurOdys Therapeutics
PrivateLast Round
Pre Seed
Mar 15, 2026
Company Overview
NeurOdys Therapeutics is a biotechnology company developing small molecule therapies for neurodegenerative disorders such as Alzheimer's and Parkinson's diseases.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeurOdys Therapeutics Comps
Public and private peers based on sector, stage, and business model.
NeurOdys Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Mar 15, 2026 |
NeurOdys Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Expert Systems Inc. | Pre Seed |
| Torrey Pines Investment LLC | Pre Seed |
| Rambam AG | Pre Seed |
| NLC Health Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 15, 2026
Led by NLC Health Ventures and Rambam AG.
NeurOdys Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeurOdys Therapeutics's valuation, stock price, and market status.
